Skip to content
Heavy Metal Index

TOXICOLOGICAL SCIENCES, 2021, 1–15

Source

This source page is a mechanical bulk-ingest record for a PDF in the research-pulls corpus.

Page snapshot
Cited by3 pages
Metals measured1
Evidence tierB
Year2021

Overview

This source page is a mechanical bulk-ingest record for a PDF in the research-pulls corpus. It preserves source-level identity, routeable product/analyte scope, and exact extracted numeric lines for later human or fresh-context audit. It does not derive HMTc thresholds, percentiles, or brand-by-brand comparisons.

Key numbers

The worker extracted the full PDF text with layout preservation twice and compared extraction hashes before commit. The following lines are copied from numeric/table-bearing regions of the PDF and retain the source units and wording where legible:

  • Fewer than 21 genes were altered in the crypt compartment of mice exposed to 0.1-5 ppm Cr(VI) for 7 or 90 days, which
  • increased to hundreds or thousands of genes at 20 ppm Cr(VI). Consistent with histological evidence for crypt
  • The oral carcinogenicity of hexavalent chromium (Cr(VI)) was carcinogenicity in the mouse small intestine occurs at 30 ppm
  • demonstrated in a 2-year cancer bioassay in rats and mice (NTP, and in the rat oral cavity at 180 ppm (NTP, 2008; Stout et al., 2009).
  • Specifically, median and 95th percentile Cr(VI) levels in U.S. water events in mice has leveraged Cr(VI) data (Bhat et al., 2020).
  • sources are 0.001 and 0.003 ppm, respectively (McNeill et al., 2012; In 2010, a research effort was initiated to specifically inform
  • 180 ppm Cr(VI) for 90 days was primarily detected in the intesti- action (PCR) primer “landing sites.” Following PCR (at which
  • pression in intestinal sections of mice exposed to 0.1–180 ppm ing packages in the R software environment, version 3.5.2
  • tions (Figure 1). Tissue fractionation allows for the determina- deviations below the mean number of genes sequenced per
  • Animal treatment and tissue preparation. Animal husbandry, study a false discovery rate (FDR) < 10% for any chosen comparison be-
  • 520 mg/l. The estimated doses across the two exposure dura- ducted using the BMDExpress software (v2.2) (Phillips et al.,
  • tions are shown in Table 1. After 7 and 90 days of exposure (re- 2019). Normalized expression data for all samples as generated
  • tines were fixed in 10% neutral-buffered formalin, embedded in gene identifiers. A Williams trend test (with p value cutoff ¼ .05)
  • Table 1. Estimated Doses of Cr(VI) Intake Based on Drinking Water Identification of pathway-level alterations across concentrations.
  • (ie, an FDR of < 10% as described above) were tested for overrep- Confirmation of Tissue Compartment Isolation
  • FDR < 10% were considered significantly enriched. untreated animals, as was the expression of several genes spe-
  • nal crypt and villus samples from female mice exposed to tap (Figure 3 and Supplementary Table 1). These compartment-
  • water or 0.1–180 ppm Cr(VI) in the drinking water for 7 or specific differences were more significant at day 91 compared
  • fresh intestinal tissue and microarray analysis of gene expres- all concentrations except for 1.4 ppm relative to the time-
  • villi at both time points (Table 2 and Figure 4). There was very there is a time component, the number of DEGs in the villi pla-
  • minimal transcriptomic response at both days 8 and 91 in the teaued at approximately 3000 at  5 ppm (Figure 4).
  • crypt at concentrations < 20 ppm (4.9 and 4.6 mg Cr(VI)/kg bw/ In addition to differences in the number of genes that were
  • can be found in Supplementary Table 3). The DEGs in each of also compared between groups to understand the overlap (and
  • these low-dose groups were nearly identical. For example, the lack thereof) of DEGs between the compartments. At 180 ppm
  • 1.4 and 5 ppm, whereas six out of the nine DEGs at 0.1 ppm were degree of overlap, as well as similarity in the magnitude of fold
  • exception of 0.1 ppm at day 8), and qualitatively appear to fol- opposite direction (cross pattern of black points in the lower
  • Table 2. Number of Significantly DEGsa in Each Group
  • Defined by comparison to control mice at the same timepoint with BH-adjusted p value < .1 (ie, FDR <10%).
  • mg/kg bw/day shown in ranges to represent the estimated Cr(VI) dose across the 2 timepoints (see Table 1).
  • Figure 5). At day 91 there was significant overlap in DEGs (black Table 3. Number of Significantly Dose-Responsive Probes and Genes
  • termined by a winning model fit p value  .1 (Supplementary in the crypt at day 91 (Table 4). The enrichment of these tran-
  • Table 3). When probes were collapsed to individual genes, a to- scriptional signaling gene sets was driven by upregulated genes
  • tal of 13 395 genes were significantly dose-responsive (Table 3 within the gene sets, and was more significant at day 91 than at
  • crypts than villi, as evidenced by the different heights of the ac- median BMD values were in the villus at day 91 and included:
  • cumulation curves, as well as the leftward shift in the day 91 vil- Sialic acid metabolism (downregulated genes, 0.16 mg/kg bw/
  • tion of ERBB2 signaling (downregulated genes, 0.67 mg/kg bw/
  • Functional Classification of Dose-Responsive Genes day; Table 5).
  • Table 4. Top 5 Most Significantly Enriched Gene Sets by Functional Classification Within BMD Analysis (Defined by Lowest p Value From
  • “Mitotic G1 phase and G1/S transition” (median BMDs ranging 1996). The Fanconi anemia pathway is activated by hypoxic
  • concentration between 20 and 60 ppm Cr(VI)) (Figure 7 and lation of markers of hypoxic stress (eg, significant increase in
  • Supplementary Table 4). The enrichment of these gene sets re- the hypoxia-inducible factor-alpha (Hif1-a) gene in the crypt at
  • genes for the crypt, with such gene sets representing some of the tions of Cr(VI) (Supplementary Table 2). Gene sets related to

Methods (brief)

  • while subtle in the villus, when compared with samples from time-matched controls. Minimal transcriptomic evidence of
  • tional studies have proved invaluable for informing the MOA, then processed individually (total of 140 samples) at BioSpyder
  • (XRF) microscopy has revealed that chromium does not distrib- transcriptome (each gene has 1–3 probes). Nuclease digestion of
  • samples containing differentiated villus enterocytes exposed to braries from each sample were sequenced (single-end, 50 bp
  • employed whole-genome microarray analysis of homogenized quence. Samples with an overall sequencing depth (total reads
  • duodenal samples (Kopec et al., 2012a,b; Rager et al., 2017), the across all probes) lower than two standard deviations below the
  • present study used RNA sequencing following microdissection mean sequencing depth across all samples, or with gene diver-
  • tion of differential responses in two functionally distinct sample were excluded from the comparative analysis. Count
  • regions of the intestinal mucosa that receive vastly different data from all samples that passed this sequencing depth quality
  • chromium dosimetry and histopathological evidence of toxicity. was used to normalize data such that sample-to-sample varia-
  • tions are shown in Table 1. After 7 and 90 days of exposure (re- 2019). Normalized expression data for all samples as generated
  • Figure 1. Schematic detailing and comparing the sample preparation and study design included in this study (right) and previous studies (left) by Kopec et al. (2012a,b)
  • across all samples was selected as the representative gene to be
  • Figure 2. Principal components analysis plot of all samples included in the analysis. The different tissue compartments and timepoints are represented by color (see
  • a molecular signaling pathway) are significantly concordant be- 90 days. All sample libraries passed quality control require-
  • tween various defined groups (in the case presented herein, dif- ments for sequencing. Following sequencing, five samples were
  • and control mice, using the Wald statistic as determined with section). Each failed sample was from an animal in a different
  • DESeq2). The GSEA statistical method was applied within the treatment group (ie, no two failed samples were from the same

Implications

This page makes the source discoverable for category-level evidence routing. Values remain source-native and should be used only with the stated matrix, species, basis, geography, and censoring context from the paper. The page does not convert total mercury to methylmercury or use total arsenic as inorganic arsenic.

Wiki pages this source may touch

Verification notes

  • Identity check: DOI, raw handle, candidate cite-key, and SHA-256 were compared against existing wiki/sources/ pages before creation.
  • Full-PDF read: pdftotext -layout was run on the full PDF twice; extracted text hashes matched before the page was written.
  • Numeric verification: numeric/table-bearing lines were selected mechanically from the verified extraction and preserved without unit conversion or rounding.
  • Brand firewall: the worker skips PDFs when extracted numeric lines appear brand/manufacturer-sensitive; this page contains category-level or species-level evidence only.
  • HMTc firewall: no threshold, percentile, pass/fail, clean/dirty, or certification math is stated.

Update history

The five most recent substantive edits to this page, classified major (evidence or structure moved), correction (a published value or statement was wrong and has been fixed), or minor (narrative rewritten without changing the underlying evidence). Each description is derived from what the edit did to this page; the linked commit is the authoritative record, routine regeneration passes are excluded, and the full version history lives in git. When DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.

CommitDateChangeDescription
b01ec52c2026-08-04major2 sections added
d49e450f2026-08-03major5 sections added; narrative text revised